Elevate your laboratory’s diagnostic capabilities with our comprehensive portfolio of Real-Time RT-PCR kits, engineered for the precise detection of critical genetic markers associated with AML and ALL. Covering a broad spectrum of clinical needs—from targeted analysis of the JAK2 V617F mutation and WT-1 expression to high-sensitivity screening and typing of major fusion genes like BCR-ABL, PML-RARα, AML1-ETO, and CBFB-MYH11—our assays provide robust, reproducible data essential for accurate patient management. Designed for seamless integration into clinical workflows, our molecular solutions ensure the diagnostic reliability and speed required to support informed, personalized treatment decisions in hematological oncology.
